Jose J. Ruiz

Insights

Medical device manufacturing in Mexico: the four leadership roles hardest to fill in 2026

Medical device manufacturing in Mexico in 2026: which leaders Tijuana, Juárez and the Bajío need under the FDA's new QMSR, an open Section 232 probe and the USMCA review.

Flat-vector editorial illustration: three executive figures review an oversized catheter and a clipboard with a check mark, on a cream background with a plant and a coral paper airplane.

Medical device manufacturing in Mexico got harder to staff at the top in 2026, for three reasons that arrived at once. The FDA changed its quality rule for device makers. The United States still has an open investigation that could put tariffs on medical devices. And investment keeps arriving that needs leaders who do not yet exist in sufficient numbers. If you run a US or European device company with plants in Mexico, that changes which roles you fill first and how long each one takes.

I write from practice. I lead Alder Koten, a bilingual retained executive search firm with offices in Mexico City, Monterrey, Guadalajara and Houston. We do medical device executive search in Tijuana, Mexicali, Ciudad Juárez, Reynosa and the Bajío. What follows is what we are hearing from clients in the sector this year. For an overview of the practice itself, see our medical device manufacturing executive search page.

What is happening in Mexico’s medical device industry

The border carries most of the output. In the third quarter of 2026, Mexico exported US$2.84 billion in medical instruments and appliances. Baja California shipped US$1.075 billion, Chihuahua US$932 million and Tamaulipas US$439 million (Data México, Ministry of Economy, 2026). Baja California alone has about 100 device plants, 73 of them in Tijuana, with more than 100,000 direct jobs and roughly 95% of output exported, according to Canacintra Tijuana (El Imparcial, October 2026).

Investment keeps coming, and not only to the border. Intuitive opened a third building in Mexicali, 440,000 square feet; the company employs about 4,700 people there and makes more than 95% of the instruments for its surgical system (La Jornada, April 2026). In May, Abbott announced 3.5 billion pesos for a new facility in Querétaro that will create 1,200 jobs by 2030 (El Financiero, May 2026). The sector is starting to grow in the Bajío, as we described in our piece on executive search in Querétaro.

The quality rule changed. Since February 2, 2026, the FDA’s Quality Management System Regulation (QMSR) has been in force, incorporating ISO 13485:2016 into the rules for device manufacturers. On the same day the FDA retired its previous inspection technique and began using a new inspection program (FDA, 2026). For a Mexican plant shipping to the United States, that means revisiting procedures, records and inspection readiness under new rules.

Trade uncertainty has not been resolved. The US Commerce Department opened a Section 232 investigation into medical devices, equipment and consumables on September 2, 2025. As of November 9, 2026, no report, proclamation or tariff had been published, and one could come at any time (TariffOS, November 2026). Meanwhile, the United States declined on July 1, 2026 to renew USMCA in its current form; the agreement remains in force but moves into annual reviews (ILS, July 2026). Since the first negotiating round, both governments have named medical devices among the sectors where they want regulatory compatibility (USTR, May 2026).

Medical device executive search: the four hardest roles

1. Director of quality and regulatory affairs. This is the role we are asked for most this year. The person has to run the quality system under QMSR, prepare the plant for FDA inspections under the new program, keep sanitary registrations current with Cofepris (Mexico’s health regulator) and, often, answer to European requirements as well. There are quality directors with device experience in Mexico, but few have led a full FDA inspection, and fewer still have done it under the rules in force since February. Start this search before the seat is empty.

2. Plant director for a regulated operation. A catheter, surgical instrument or sterile disposables plant does not run like an auto parts plant. Process validation, cleanrooms, sterilization, change control and lot-level traceability are daily work. Many companies recruit from automotive or aerospace because the pools are bigger. That works when the person has already worked with validated processes and strict documentation, and fails when they bring only volume and cost experience. We cover this on our plant director executive search page.

3. Director of trade compliance and rules of origin. With a Section 232 investigation open and USMCA under annual review, whether a product qualifies as regionally originating has a direct cost consequence. This role runs the IMMEX program, rules of origin, tariff classification and the relationship with customs brokers on both sides of the border. Five years ago it was usually a manager-level job; today many companies are raising it to director, reporting to the general manager.

4. Director of engineering and product transfer. When a company moves a line from the United States, Costa Rica or Asia, someone has to transfer the process, validate it and reach production without losing regulatory approval. In Tijuana, the cluster has also announced plans for a medical device innovation and development center focused on design, engineering and R&D (Mexico Business News, November 2026). That is starting to create product engineering roles that used to exist only at headquarters.

What changes for the hiring company

Talent from other industries helps, but does not replace regulated experience. A director from automotive brings operating discipline and volume management. What you need to verify is whether they have worked under a quality system that answers to a regulator. That difference does not show on a résumé; it shows in how they describe a deviation, a complaint or a recall.

The border and the Bajío pay differently. In Tijuana, many executives live in San Diego and cross daily, which changes the compensation and package conversation. In the Bajío, the same role competes with aerospace and automotive for the same engineers. Benchmarking only against other device plants leaves the offer short.

The transfer sets the clock, not the vacancy. If a new line has to be validated by late 2027, the engineering and quality directors need to be hired at least six to nine months earlier. A retained search in Mexico runs 90 to 120 days from engagement to signed offer, plus the candidate’s notice period. Start when the equipment arrives and you have no margin left to validate.

A sector where everyone knows everyone. There are few quality directors with FDA inspection experience in Tijuana or Juárez, and they know each other. For replacements or sensitive new roles, use a confidential executive search.

How we work

We run medical device searches with our methodology: a written profile before we go to market; a map of device plants in Tijuana, Mexicali, Juárez, Reynosa and the Bajío, plus Mexican professionals now working in the United States; a structured assessment of the shortlist; and one accountable partner from start to finish. More on the border market on our Tijuana page.

Frequently asked questions

Which role should a new medical device plant in Mexico fill first? Almost always the director of quality and regulatory affairs, together with the plant director. Without an approved quality system there is no commercial production, and sanitary registration and FDA readiness take months. Hiring the quality director late is one of the most common causes of delayed start-ups.

How much does medical device executive search cost in Mexico? A retained search for a director role typically costs 25% to 33% of first-year total cash compensation, paid in three installments (ExecSignals, April 2026). For quality roles with few available candidates, a retained model is almost always the right fit.

Can an automotive plant director run a medical device plant? Yes, if they have already worked with validated processes, strict documentation and demanding external audits. If their experience is only volume and cost reduction, the regulatory learning curve is usually longer than the company can afford. Ask for specific cases: a deviation they investigated, an audit they led.

How does the USMCA review affect hiring in this sector? It makes the trade compliance and rules-of-origin role more important, and it means the general manager has to understand the issue. While Section 232 remains open, companies that can prove regional origin are better positioned. That is solved by people who know the rules, not only by customs brokers.

If you are hiring leadership for a medical device plant in Mexico, whether for a start-up, a line transfer or a replacement, let’s talk. The first conversation is about what the person has to accomplish, before we talk about candidates.

Jose J. Ruiz is CEO of Alder Koten and Chairman of Anker Bioss.

Topics

  • Medical device executive search
  • Medical device manufacturing Mexico
  • Tijuana
  • FDA QMSR
  • USMCA
  • Executive search Mexico